Priority Date: 25.11.11 (FR 20110060787)

COMBINATION THERAPY USING ANTI - CD20 ANTIBODY AND HUMAN IL-15

  • Application ID: EP12798647
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). F. Hoffmann-La Roche AG is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 230 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 25.11.2011 - Priority Date (FR 20110060787)
  • 30.05.2013 - Publication A1 (WO2013076183)
  • 01.10.2014 - Publication A1 (EP2782600)